EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Adjuvant Radiation for High Risk Bladder Cancer

Not Applicable

Terminated

Conditions: Transitional Cell Carcinoma of the Bladder
Squamous Cell Carcinoma of the Bladder
Stage IV Bladder Cancer
Bladder Cancer
Stage III Bladder Cancer

Interventions: Radiation: 3D conformal radiation therapy

First Posted Date: 2013-10-01

Last Posted Date: 2022-03-02

Lead Sponsor: Emory University

Target Recruit Count: 19

Registration Number: NCT01954173

Locations: 🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

Mechanisms of Intradialytic Hypertension

Not Applicable

Completed

Conditions: Renal Failure Chronic Requiring Hemodialysis
Haemodialysis-induced Symptom
Hypertension

Interventions: Other: Mindfulness Meditation
Other: Health Education

First Posted Date: 2013-09-20

Last Posted Date: 2021-07-15

Lead Sponsor: Emory University

Target Recruit Count: 49

Registration Number: NCT01947673

Locations: 🇺🇸
Emory Dialysis Clinics, Atlanta, Georgia, United States

Preventing Depression in People With Epilepsy: an Extension of Project UPLIFT

Not Applicable

Completed

Conditions: Epilepsy
Depressive Symptoms
Depression
Seizure Disorder

Interventions: Behavioral: Project UPLIFT

First Posted Date: 2013-09-13

Last Posted Date: 2014-02-12

Lead Sponsor: Emory University

Target Recruit Count: 130

Registration Number: NCT01941706

Locations: 🇺🇸
University of Texas Health Science Center, Houston, Texas, United States
🇺🇸
Rollins School of Public Health, Atlanta, Georgia, United States
🇺🇸
University of Washington, Seattle, Washington, United States

and more 1 locations

FACBC for Head and Neck Cancers

Early Phase 1

Withdrawn

Conditions: Cancers of the Head and Neck

Interventions: Drug: FACBC

First Posted Date: 2013-09-02

Last Posted Date: 2018-02-05

Lead Sponsor: Emory University

Registration Number: NCT01933269

Definity for Ultrasound of Intraocular Tumors

Withdrawn

Conditions: Ocular Melanoma

First Posted Date: 2013-08-29

Last Posted Date: 2022-02-23

Lead Sponsor: Emory University

Registration Number: NCT01930968

Locations: 🇺🇸
Emory Eye Center, Atlanta, Georgia, United States

Efficacy of Swedish Massage Therapy on Cancer-related Fatigue in Cancer Survivors

Phase 2

Completed

Conditions: Cancer Related Fatigue

Interventions: Other: Swedish massage therapy
Other: Light touch therapy

First Posted Date: 2013-08-21

Last Posted Date: 2016-07-11

Lead Sponsor: Emory University

Target Recruit Count: 66

Registration Number: NCT01926678

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States

A Single Wintertime Dose of Vitamin D3 to Prevent Winter Decline in Vitamin D Status in Healthy Adults

Phase 4

Completed

Conditions: Vitamin D Deficiency

Interventions: Dietary Supplement: Placebo
Dietary Supplement: 250,000 IU cholecalciferol as single, oral dose

First Posted Date: 2013-08-19

Last Posted Date: 2017-07-13

Lead Sponsor: Emory University

Target Recruit Count: 28

Registration Number: NCT01924910

Locations: 🇺🇸
Emory University Campus, Atlanta, Georgia, United States

Study of Dehydration and Cognition in Pupils in Zambia

Not Applicable

Completed

Conditions: Dehydration

Interventions: Other: Water

First Posted Date: 2013-08-16

Last Posted Date: 2019-05-06

Lead Sponsor: Emory University

Target Recruit Count: 292

Registration Number: NCT01924546

Locations: 🇿🇲
Chipata, Chipata, Zambia

D-cycloserine and Treatment of Feeding Disorders

Phase 1

Completed

Conditions: Specific Phobia
Feeding Disorders

Interventions: Behavioral: Behavioral Intervention
Drug: d-cycloserine (DCS)
Drug: Placebo

First Posted Date: 2013-08-16

Last Posted Date: 2014-10-23

Lead Sponsor: Emory University

Target Recruit Count: 16

Registration Number: NCT01923896

Locations: 🇺🇸
Marcus Autism Center - Children's Healthcare of Atlanta, Atlanta, Georgia, United States

Dysport for the Treatment of OMD

Phase 1

Completed

Conditions: Oral Dystonia
Tardive Dystonia

Interventions: Drug: Low Dose - AbobotulinumtoxinA

First Posted Date: 2013-08-13

Last Posted Date: 2017-11-17

Lead Sponsor: Emory University

Target Recruit Count: 18

Registration Number: NCT01921270

Locations: 🇺🇸
Wesley Woods Health Center; Emory University Hospital, Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy